Kanesa-thasan Niranjan 4
4 · Icosavax, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Kanesa-thasan Niranjan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+110,000→ 110,000 totalExercise: $9.06Exp: 2033-02-14→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.